Brief: Aurobindo Pharma Says US FDA Conducted Inspection At Lannett Company Llc From 17Th To 21St August 2026
24/08/2026 04:33
BRIEF-Aurobindo Pharma Says US FDA Conducted Inspection At Lannett Company Llc From 17Th To 21St August 2026 Aug 24 (Reuters) - Aurobindo Pharma Ltd ARBN.NS:
AUROBINDO PHARMA- US FDA CONDUCTED INSPECTION AT LANNETT COMPANY LLC FROM 17TH TO 21ST AUGUST 2026
AUROBINDO PHARMA- INSPECTION CONCLUDED WITH FOUR OBSERVATIONS, WHICH ARE PROCEDURAL IN NATURE
Source text: [ID:]
Further company coverage: ARBN.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurobindo Pharma
See all newsBrief: Aurobindo Pharma Gets Tax Order Confirming Total Disputed Amount 46 Million Rupees
India's Aurobindo Pharma falls after US FDA flags observation at Telangana facility
Brief: Aurobindo Pharma Says US FDA Inspected API Manufacturing Facility Of Unit Apitoria Pharma
Brief: Aurobindo Pharma Gets USFDA Final Approval For Beclomethasone Dipropionate HFA Inhalation Aerosol
Brief: Aurobindo Pharma Says US FDA Inspected Unit-IV Of Apitoria Pharma From September 7 To September 11